Jeffrey Newcorn
Medical Director, Associate Professor, Primary Investigator · Icahn School of Medicine at Mount Sinai
Credentials: · ·
History
- Present
Associate Professor · Icahn School of Medicine at Mount Sinai
- 1981–1983
Child and Adolescent Psychiatry
- 1977–1981
Psychiatry
Research
Review · American Journal of Psychiatry · 1991 · 1,062 citations
Review · Neuroscience & Biobehavioral Reviews · 2021 · 976 citations
Journal of the American Academy of Child & Adolescent Psychiatry · 2001 · 772 citations
- JH
79 papers
- EA
40 papers

40 papers
- BV
34 papers
- HA
32 papers

31 papers
- GE
29 papers
- JM
24 papers
Grants
- 2026–2031
National Institute of Mental Health · R01
PI · $839.5K · Upstate Medical University
- 2019–2023
Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
National Institute on Drug Abuse · R21
Contact PI · $466.1K · Icahn School of Medicine at Mount Sinai
- 2018–2022
Stimulant vs. Non-Stimulant Treatments and Reward Processing in Drug-Naive Youth at SUD Risk
National Institute on Drug Abuse · R21
Contact PI · $466.1K · Icahn School of Medicine at Mount Sinai
- 2012–2018
Imaging Stimulant and NonStimulant Treatments for ADHD: A Network-Based Approach
National Institute of Mental Health · R01
Contact PI · $3.2M · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2024–2026
A Comparative Study to Evaluate a Novel Algorithm As a Diagnostic Aid for ADHD in Youth Ages 6-17.
Principal investigator · Recruiting
MindTension
- 2019–2023
Brain Indices of Stimulant Treatment in Drug-Naive Youth at Risk for Substance Use Disorder
Principal investigator · Completed · Phase 4
Jeffrey Newcorn
- 2019–2025
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Principal investigator · Unknown · Phase 4
Icahn School of Medicine at Mount Sinai
- 2018–2025
Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD
Principal investigator · Unknown · Phase 4
Icahn School of Medicine at Mount Sinai

